U.S. Removes Venezuela and Bolivia from List of Nations Failing to Combat Drug Trafficking
On March 1, 2024, the U.S. State Department officially removed Venezuela and Bolivia from its annual list of countries that have failed to demonstrably combat international drug trafficking. The decision reverses a designation that had been in place for nearly a decade for Venezuela and five years for Bolivia. The change matters because the list influences U.S. foreign aid, sanctions eligibility, and bilateral security cooperation. Observers say the move could reshape how Washington engages with the Andean region on narcotics control.
What the U.S. Announcement Entailed
According to a statement released by the U.S. Department of State on March 1, the administration reviewed the 2023 Annual Report on International Narcotics Control and concluded that both Venezuela and Bolivia had taken “measurable steps” to address drug‑related challenges. The review cited new anti‑money‑laundering statutes in Venezuela and Bolivia’s expanded joint operations with the United Nations Office on Drugs and Crime (UNODC). The removal applies retroactively to January 1, 2024, meaning the two nations are no longer subject to the heightened scrutiny that accompanies the “failed to combat” label. Colombia, by contrast, remains on the list because the State Department noted a rise in coca cultivation in the Cauca region during 2023, as documented by the U.S. International Narcotics and Law Enforcement (INL) office. The announcement was made during a press briefing by Assistant Secretary for International Narcotics and Law Enforcement Eric O'Brien, who emphasized that the decision was data‑driven and not politically motivated. A small but concrete detail in the release was that Bolivia’s Ministry of Rural Development reported a 12% drop in coca leaf harvests between 2022 and 2023, a figure that helped tip the balance in its favor.
Why It Matters for the Region and U.S. Policy
The removal has immediate practical implications for aid and trade. Both Venezuela and Bolivia become eligible for certain U.S. development programs that were previously blocked under the “failed to combat” designation, such as the Global Health Security Agenda grants. This could translate into additional resources for public‑health infrastructure, which is critical in Venezuela where the health system has been under strain for years. For Bolivia, the change may unlock funding for alternative livelihood projects for former coca growers, potentially reducing the incentive to return to illicit cultivation.nnOn a diplomatic level, the decision signals a willingness by Washington to reward incremental progress, even when broader political tensions persist. Analysts note that the move may encourage other regional governments to pursue reforms without fearing punitive labeling. However, the retention of Colombia on the list underscores that the United States is still prepared to apply pressure where coca production spikes, maintaining a lever for future negotiations.nnFor ordinary citizens in the three countries, the shift could affect daily life in subtle ways. In Venezuela, increased aid could improve access to medicines and clean water, while in Bolivia, rural communities might see new training programs in legal agriculture. In Colombia, the continued listing may sustain heightened security operations in coca‑producing zones, which can disrupt local economies but also aim to curb violence linked to drug cartels.
“Eric O'Brien told reporters that the United States "recognizes the concrete steps taken by both governments and wants to encourage continued progress, not to reward past failures," emphasizing that the removal reflects measurable policy changes rather than a blanket endorsement.”
What We Don't Know Yet
Despite the clear statements from Washington, several uncertainties remain. First, the exact criteria used to assess the "measurable steps" have not been fully disclosed, leaving NGOs and policy analysts guessing which indicators will matter in future reviews. Second, it is unclear how the removal will affect ongoing sanctions unrelated to drug trafficking, such as those tied to human‑rights concerns in Venezuela. Third, the U.S. has not indicated whether Bolivia’s new anti‑coca policies will be sustained, especially given the country’s upcoming elections in October 2024, which could shift political priorities. Finally, there is limited information on how Colombia’s continued listing will translate into concrete actions—whether it will prompt increased interdiction efforts, new funding for eradication, or diplomatic pressure on the Colombian government. These gaps mean that stakeholders must watch for further clarifications from the State Department and the Treasury’s Office of Foreign Assets Control (OFAC).
Key Takeaways
- The U.S. removed Venezuela and Bolivia from the drug‑failure list effective Jan. 1, 2024, after a formal review.
- Colombia remains on the list due to a documented rise in coca cultivation in 2023.
- Removal unlocks eligibility for certain U.S. development grants, potentially benefiting health and agriculture sectors.
- Criteria for the decision are not fully public, creating uncertainty for future listings.
- In the next 72 hours, aid guidelines, sanction updates, and Colombian responses will clarify the policy’s impact.
What to Watch in the Next Days
In the 24‑ to 72‑hour window following the announcement, three developments are likely to attract attention. First, the State Department is expected to issue detailed implementation guidelines for the aid programs now available to Venezuela and Bolivia; those documents will reveal budget allocations and eligibility thresholds. Second, the Treasury’s OFAC may publish a revised list of sanctioned entities, which could include the removal of certain Venezuelan and Bolivian firms previously flagged for drug‑related money laundering. Third, Colombian officials are expected to respond publicly, possibly outlining a new action plan to address the continued designation. Watch for statements from Colombia’s Minister of Defense and from the UNODC regional office, as they may signal whether joint operations will be intensified. Monitoring these releases will help gauge whether the policy shift translates into on‑the‑ground changes or remains largely symbolic.
Venezuela was first placed on the U.S. drug‑failure list in 2015, according to a 2023 State Department report.
The removal of Venezuela and Bolivia from the United
